西妥昔单抗联合化疗治疗消化系统肿瘤的临床研究

Clinical study of cetuximab combined with chemotherapy in the treatment of tumor of digestive system

目的:研究西妥昔单抗联合化疗治疗消化系统肿瘤的临床效果。方法:2012年3月-2013年3月收治消化系统肿瘤患者80例,将其随机分为对照组和观察组各40例,对照组使用一般的治疗方法,观察组使用西妥昔单抗联合化疗治疗,比较两组的治疗效果。结果:观察组的总有效率90%,对照组的总有效率70%,观察组的治疗效果明显优于对照组,差异有统计学意义(P<0.05)。结论:西妥昔单抗联合化疗在治疗消化系统肿瘤方面有十分积极的临床效果。

Objective:To explore the clinical effect of cetuximab combined with chemotherapy in the treatment of tumor of digestive system.Methods:80 patients with digestive system tumor were selected from March 2012 to March 2013.They were randomly divided into the control group and the observation group with 40 cases in each group.The control group were treated with general treatment.The observation group were treated with cetuximab combined with chemotherapy.We compared the treatment effect of the two groups.Results:In the observation group,the total efficiency was 90%.In the control group,the total efficiency was 70%.The treatment effect of the observation group was obviously better than the control group,and the difference was statistically significant(P<0.05).Conclusion:The clinical effect of cetuximab combined with chemotherapy in the treatment of tumor of digestive system is significant.